Andrew is currently the Chief Global Medical Affairs Officer for Janssen. Prior to this position, and as Vice President of Immunology Medical Affairs, Andrew was responsible for leadership and oversight of Immunology Medical Affairs activities supporting REMICADE®, SIMPONI®, SIMPONI ARIA®, STELARA® and TREMFYA® for a wide range of diseases, including Rheumatoid Arthritis, Crohn’s Disease, Ulcerative Colitis and Psoriasis. Andrew joined Johnson & Johnson in 2003 taking on roles with increasing responsibilities, working across both Medical Affairs and Research & Development in Neuroscience, Immunology and Oncology. He has led numerous Phase 1 through 4 clinical studies and has co-authored over 35 peer reviewed journal articles. Andrew serves on the Board for Life Sciences Pennsylvania. Andrew graduated Magna Cum Laude from Columbia University and earned his medical degree from Harvard Medical School. He completed his residency training in Internal Medicine at New York Hospital/Weill Cornell Medical College. Andrew enjoys mountain climbing, swimming, and playing the clarinet.